RecruitingNCT07012759

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Novel Pleural Effusion Biomarkers Screening and Evaluation in Lung Adenocarcinoma Patients

Sponsor

Fu Jen Catholic University

Enrollment

100 participants

Start Date

Jun 10, 2025

Study Type

OBSERVATIONAL

Conditions

Lung Adenocarcinoma Pleural Effusion Biomarkers

Summary

This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting fluid from around the lung (pleural effusion) in patients with lung adenocarcinoma — a type of lung cancer — to look for biomarkers that could help predict treatment response or track disease progression. **You may be eligible if...** - You are 18 or older - You have been diagnosed with lung adenocarcinoma - Your doctor has determined you need a procedure to drain fluid around your lung (thoracentesis) - You are willing to sign informed consent **You may NOT be eligible if...** - You are under 18 years old - You have a different type of cancer (other than lung adenocarcinoma) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.